戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 m, 4 Meige syndrome, and 26 benign essential blepharospasm.
2 ected by mouth/tongue dystonia compared with blepharospasm.
3 agnosed with paraneoplastic encephalitis and blepharospasm.
4 reducing the likelihood of disorders such as blepharospasm.
5             Results: Of the 74 patients with blepharospasm, 39 (52.7%) used alleviating maneuvers (me
6                Spread was observed in 50% of blepharospasm, 8% of cervical dystonia, 17% of hand dyst
7 ticollis, nine with writer's cramp, two with blepharospasm and 16 healthy control subjects participat
8 r 2013) of 74 patients with benign essential blepharospasm and 56 patients with hemifacial spasm who
9 e the number of injection visits required by blepharospasm and hemifacial spasm patients during their
10 e and type of alleviating maneuvers used for blepharospasm and hemifacial spasm, dystonia severity, a
11 he only permanent, nonsurgical treatment for blepharospasm and hemifacial spasm.
12 t injection into the eyelid for treatment of blepharospasm and hemifacial spasm.
13 ternative treatment option for patients with blepharospasm and hemifacial spasm.
14 nia manifested by involuntary eyelid spasms (blepharospasm) and lower facial and jaw spasms (oromandi
15 cember 1989 for three disorders (strabismus, blepharospasm, and hemifacial spasm), the number of indi
16 transplant characterized by akinetic mutism, blepharospasm, anomic aphasia, and delirium.
17                  The second is patients with blepharospasm-associated deformities.
18 ical technique for treating benign essential blepharospasm (BEB) and apraxia of eyelid opening (ALO).
19 BoNT-A) therapy in cases of benign essential blepharospasm (BEB).
20 n (BoNT) on blink rate (BR) in patients with blepharospasm (BSP) and increased blinking (IB).
21 nnaire designed to identify eye symptoms and Blepharospasm Disability Index (BSDI) before and 1 month
22 ifference, 1 [95% CI, 0-2]; P = .01) and the Blepharospasm Disability Index severity score (median sc
23 f several neuromuscular disorders, including blepharospasm, dystonia, spasticity, and cerebral palsy
24 neuvers and those who did not, in either the blepharospasm group (150 vs 125 units; Hodges-Lehmann me
25 ndibular region (42.2%) and neck (22.4%) for blepharospasm, hand (3.5%) for cervical dystonia and nec
26 option for the treatment of focal dystonias: blepharospasm, hemifacial spasm, and apraxia of eyelid o
27 in A is the most commonly used treatment for blepharospasm, hemifacial spasm, and other focal dystoni
28 otrophic lateral sclerosis, benign essential blepharospasm, hemifacial spasm, and Tourette syndrome.
29 clinical triad of epiphora, photophobia, and blepharospasm; increased intraocular pressure; corneal c
30                      Although paraneoplastic blepharospasm is rare, it is an important diagnosis to b
31 year-old woman with the rare complication of blepharospasm-like symptoms appearing contralateral to a
32 a (N = 45), laryngeal dystonia (N = 49), and blepharospasm (N = 49).
33 ne) (n = 13), FHD (n = 15), benign essential blepharospasm (n = 9), cervical dystonia (n = 10) and in
34   Importance: Patients with benign essential blepharospasm or hemifacial spasm are known to use botul
35 f alleviating maneuvers for benign essential blepharospasm or hemifacial spasm correlates with diseas
36               Women predominated over men in blepharospasm, oromandibular, laryngeal and cervical dys
37      Myectomy remains essential for treating blepharospasm patients and the most common indication is
38 icin injections in reducing muscle spasms in blepharospasm patients but with increased safety to the
39 oses similar to those proposed for the human blepharospasm patients in Phase I and II trials.
40  botulinum toxin treatment for patients with blepharospasm (r = 0.23; P = .049) and patients with hem
41      This is the only case of paraneoplastic blepharospasm that the authors know of that was the resu
42 road array of diseases from benign essential blepharospasm to facial wrinkles.
43 4 [95% CI, 1-7]; P = .01) than patients with blepharospasm who did not use alleviating maneuvers.
44                                Patients with blepharospasm who used alleviating maneuvers scored high